Liver transplant patients monitored for hidden muscle weakness
NCT ID NCT05216991
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 26 times
Summary
This study looked at how often patients experience lasting muscle weakness after liver transplant surgery when given a drug called Sugammadex. Researchers used a device on the thumb to measure muscle response. The goal was to better understand recovery and improve anesthesia care for these patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER TRANSPLANT SURGERY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic Florida
Jacksonville, Florida, 32224, United States
Conditions
Explore the condition pages connected to this study.